Loading recalls…
Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the…
CGMP Deviations: use of an unapproved raw material
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability…